[{"indications": "Indications\u00a0anovulatory infertility\u2014see notes above", "name": "CLOMIFENE CITRATE", "breadcrumbs": ["Home", "BNF No. 63 (March 2012)", "6 Endocrine system", "6.5 Hypothalamic and pituitary hormones and anti-oestrogens", "6.5.1 Hypothalamic and anterior pituitary hormones and anti-oestrogens", "Anti-oestrogens"], "cautions": "Cautions\u00a0\n(From Anti-oestrogens: British National Formulary)\nAnti-oestrogens; polycystic ovary\r\nsyndrome (cysts may enlarge during treatment, also risk of exaggerated\r\nresponse to usual doses), ovarian hyperstimulation syndrome, uterine\r\nfibroids, ectopic pregnancy, incidence of multiple births increased (consider ultrasound\r\nmonitoring), visual symptoms (discontinue\r\nand initiate ophthalmological examination)CSM Advice\u00a0The CSM has recommended that clomifene should not normally be used for longer than 6 cycles (possibly increased\r\nrisk of ovarian cancer)", "side-effects": "Side-effects\u00a0visual disturbances (withdraw), ovarian hyperstimulation\r\n(withdraw), hot flushes, abdominal discomfort, occasionally nausea,\r\nvomiting, depression, insomnia, breast tenderness, headache, intermenstrual\r\nspotting, menorrhagia, endometriosis, convulsions, weight gain, rashes,\r\ndizziness, hair loss", "fname": "/home/david/src/nhshackday/bnf-html/www.medicinescomplete.com/mc/bnf/current/4389.htm", "doses": ["50\u00a0mg daily for 5 days, starting within about 5 days of\r\nonset of menstruation (preferably on 2nd day) or at any time (normally\r\npreceded by a progestogen-induced withdrawal bleed) if cycles have\r\nceased; second course of 100\u00a0mg daily for 5 days may be given in absence\r\nof ovulation; most patients who are going to respond will do so to\r\nfirst course; 3 courses should constitute adequate therapeutic trial;\r\nlong-term cyclical therapy not recommended\u2014see CSM advice, above"], "pregnancy": "Pregnancy\u00a0exclude pregnancy before treatment; possible effects\r\non fetal development"}]